Cargando…
Antagonizing Glutamine Bioavailability Promotes Radiation Sensitivity in Prostate Cancer
SIMPLE SUMMARY: Radiation is the standard of care for prostate cancer, but almost half the patients develop resistant disease. It is imperative to understand the reasons behind disease progression to develop more effective strategies of treatment. We determined that glutamine is a crucial nutrient i...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139225/ https://www.ncbi.nlm.nih.gov/pubmed/35626095 http://dx.doi.org/10.3390/cancers14102491 |